OncoCyte (OCX) Reports FY Loss of $3.37

OncoCyte (NASDAQ: OCX) reported FY EPS of ($3.37). Revenue for the year came in at $1.5 million.

For earnings history and earnings-related data on OncoCyte (OCX) click here.

You May Also Be Interested In

• FedEx falls 4% as CY2026 profit forecast misses expectations despite Q4 beat
• Darden Restaurants (DRI) PT Raised to $235 at Guggenheim
• KB Home (KBH) Misses Q2 EPS by 2c; Offers Outlook